DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2024 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.
Join TransCelerate for:
‘Maternal & neonatal health: Actions to improve the benefit-risk assessment of medicinal products used in pregnancy” session on 14 March from 10:40 to 11:50 a.m. with David Lewis, Global Head of Pharmacovigilance at Novartis, Amalia Alexe, Policy and Liaison Lead, QPPV Office, Advanced Accelerator Applications, A Novartis Company, and Corinne de Vries, Head of Translational Sciences at European Medicines Agency.